David W. Cescon

Princess Margaret Hospital — New Zealand

Biochemistry, Genetics and Molecular Biology · Life Sciences

52h-index13.9kcitations402works7.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(94), Advanced Breast Cancer Therapies(94), Cancer Immunotherapy and Biomarkers(63), Cancer Treatment and Pharmacology(44), Breast Cancer Treatment Studies(41)

Publications401 total

Abstract PS5-06-30: Local progression in patients with responding metastatic HER2+ breast cancer: A Case Series
Clinical Cancer Research·2026
KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy
Clinical Cancer Research·2025
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer
npj Breast Cancer·2025Open Access
A Biomimetic Buffering Hydrogel Scaffold for Long‐Term Culture of Patient‐Derived Tumor Organoids
Advanced Healthcare Materials·2025Open Access
Supplementary Figure 2 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025Open Access
Supplementary Figure 3 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025Open Access
Supplementary Figure 1 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025Open Access
Supplementary Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025Open Access
Supplementary Methods and Tables from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025Open Access
Simulating cell-free chromatin using preclinical cancer models for liquid biopsy applications
iScience·2025Open Access
Navigating Treatment Sequencing in Advanced HR+/HER2− Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging Therapies
International Journal of Molecular Sciences·2025· 1 citedOpen Access
Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer
Cancers·2025Open Access
337P Non-enrichment-based circulating tumor cells (CTCs) as predictors of late recurrence in ER/PgR-positive breast cancer (BC)
Annals of Oncology·2025
LBA21 First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase III TROPION-Breast02 trial
Annals of Oncology·2025· 8 citedOpen Access
643eP The association of circulating tumor cells with body mass index, body composition and blood biomarkers in patients with newly diagnosed metastatic breast cancer
Annals of Oncology·2025
Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays
Science Advances·2025· 5 citedOpen Access
Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy
npj Breast Cancer·2025· 5 citedOpen Access
FAM72A promotes UNG2 degradation and mutagenesis in human cancer cells
Scientific Reports·2025· 3 citedOpen Access
Abstract P1-05-30: A statistical model for integration of on-treatment circulating tumor DNA dynamics and prediction of outcomes in patients with ER+/HER2- metastatic breast cancer
Clinical Cancer Research·2025
Abstract GS3-01: Circulating tumor DNA surveillance in ZEST, a randomized, phase 3, double-blind study of niraparib or placebo in patients w/ triple-negative breast cancer or HER2+ BRCA-mutated breast cancer with molecular residual disease after definitive therapy
Clinical Cancer Research·2025· 3 cited
page 1 of 21Next →

Frequent Co-authors

Tak W. Mak(16), Benjamin Haibe‐Kains(11), Vassiliki Karantza(9), Jennifer Silvester(9), Peter Schmid(8), Andrew Wakeham(8), Javier Cortés(7), Hope S. Rugo(7), Hiroji Iwata(7), Sherene Loi(7), Chiara Gorrini(7), Kelsie L. Thu(7), Jillian Haight(7), Mathieu Lupien(7), Sylvia Adams(6), Rita Nanda(6), Wail Ba-Alawi(6), Seock‐Ah Im(5), Satoshi Inoue(5), Andrew Elia(5)